NCT00521937View on ClinicalTrials.gov

Efficacy and Safety Study of DERMAGEN® vs Conventional Treatment to Treat Diabetic Neuropathic Foot Ulcer

PHASE3UnknownINTERVENTIONAL
Enrollment

388

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

December 31, 2010

Conditions
DiabetesFoot Ulcer
Interventions
OTHER

Dermagen®

Weekly topical applications

Trial Locations (7)

Unknown

Marseille

Nancy

Nîmes

Paris

Roubaix

Thionville

Toulouse

Sponsors
All Listed Sponsors
lead

Laboratoires Genévrier

INDUSTRY

NCT00521937 - Efficacy and Safety Study of DERMAGEN® vs Conventional Treatment to Treat Diabetic Neuropathic Foot Ulcer | Biotech Hunter | Biotech Hunter